These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16630984)

  • 21. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies.
    Siddiqui A; Kowey PR
    Curr Opin Cardiol; 2006 Sep; 21(5):517-25. PubMed ID: 16900017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benefits of the implantable cardioverter-defibrillator.
    Epstein AE
    J Am Coll Cardiol; 2008 Sep; 52(14):1122-7. PubMed ID: 18804737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy.
    Bestetti RB; Theodoropoulos TA; Cardinalli-Neto A; Cury PM
    Am Heart J; 2008 Sep; 156(3):422-30. PubMed ID: 18760121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
    Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
    Das M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recent advances and limitations of medical treatment on heart failure].
    Momomura S
    Kyobu Geka; 2007 Jun; 60(6):484-7. PubMed ID: 17564066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is implantable defibrillator indicated in all patients on cardiac resynchronization therapy?
    Pieragnoli P; Ricciardi G; Colella A; Musilli N; Porciani MC; Giaccardi M; Padeletti L; Michelucci A
    Minerva Cardioangiol; 2006 Dec; 54(6):735-41. PubMed ID: 17167385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Heart failure and sudden death].
    Hirai T; Asanoi H
    Nihon Rinsho; 2005 Jul; 63(7):1155-61. PubMed ID: 16001776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mortality rates and clinical predictors of reduced survival after cardioverter defibrillator implantation.
    Thibodeau JB; Pillarisetti J; Khumri TM; Jones PG; Main ML
    Am J Cardiol; 2008 Mar; 101(6):861-4. PubMed ID: 18328854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.
    Shah B; Hernandez AF; Liang L; Al-Khatib SM; Yancy CW; Fonarow GC; Peterson ED;
    J Am Coll Cardiol; 2009 Feb; 53(5):416-22. PubMed ID: 19179199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of implantable-cardioverter-defibrillator trials on clinical management of patients with heart failure.
    Winslow RD; Pinney S; Fuster V
    Nat Clin Pract Cardiovasc Med; 2006 Feb; 3(2):86-93. PubMed ID: 16446777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk stratification for sudden death in heart failure.
    Farwell D; Gollob MH
    Minerva Cardioangiol; 2007 Jun; 55(3):379-84. PubMed ID: 17534256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of elderly heart failure recipients of ICD and CRT.
    Grimm W
    Int J Cardiol; 2008 Apr; 125(2):154-60. PubMed ID: 17976843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practical aspects of implantable defibrillator therapy in patients with congenital heart disease.
    Walsh EP
    Pacing Clin Electrophysiol; 2008 Feb; 31 Suppl 1():S38-40. PubMed ID: 18226034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy.
    Auricchio A; Metra M; Gasparini M; Lamp B; Klersy C; Curnis A; Fantoni C; Gronda E; Vogt J;
    Am J Cardiol; 2007 Jan; 99(2):232-8. PubMed ID: 17223424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DEFibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE).
    Schaechter A; Kadish AH;
    Card Electrophysiol Rev; 2003 Dec; 7(4):457-62. PubMed ID: 15071275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventing sudden death: implantable cardioverter-defibrillators in elderly cardiac patients.
    Groeneveld PW
    LDI Issue Brief; 2008; 13(6):1-4. PubMed ID: 18613344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of beta-blockers in patients with an implantable cardioverter defibrillator.
    LaPointe NM; Stafford JA; Pappas PA; Al-Khatib SM; Anstrom KJ
    Ann Pharmacother; 2009 Jul; 43(7):1189-96. PubMed ID: 19567655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early mortality in implantable cardioverter defibrillator patients: from randomized controlled trials to real life.
    Köbe J; Eckardt L
    Europace; 2009 Jun; 11(6):694-6. PubMed ID: 19470594
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of life-threatening arrhythmias in patients with chronic heart failure].
    Murakami M; Nakamura K; Ohe T
    Nihon Rinsho; 2006 May; 64(5):985-9. PubMed ID: 16689385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.